|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Division of Primary Care, School of Community Health Sciences, University Hospital, Nottingham NG7 2UH, UK
2 Hayward House, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
3 Pharmacy Department, Queens Medical Centre, University Hospital, Nottingham NG7 2UH, UK
Correspondence to:
Mrs R L Howard, Division of Primary Care, School of Community Health Sciences, University Hospital, Nottingham NG7 2UH, UK;
Rachel.howard{at}broxtowehucknall-pct.nhs.uk
Objective: To describe the drugs and types of medicine management problems most frequently associated with preventable drug related admissions to an acute medical admissions unit.
Design: Observation study.
Setting: Medical admissions unit in a teaching hospital in Nottingham, UK.
Participants: 4093 patients seen by pharmacists on the medical admissions unit between 1 January and 30 June 2001.
Main outcome measures: Proportion of admissions that were drug related and preventable, classification of the underlying causes of preventable drug related admissions, and identification of drugs most commonly associated with preventable drug related admissions.
Results: Of the admissions seen by pharmacists, 265 (6.5%) were judged to be drug related and 178 (67%) of these were judged to be preventable. Preventable admissions were mainly due to problems with prescribing (63 cases (35%)), monitoring (46 cases (26%)), and adherence to medication (53 cases (30%)). The drugs most commonly implicated were NSAIDs, antiplatelets, antiepileptics, hypoglycaemics, diuretics, inhaled corticosteroids, cardiac glycosides, and beta-blockers.
Conclusions: Potentially preventable drug related morbidity was associated with 4.3% of admissions to a medical admissions unit. In 91% of cases these admissions were related to problems with either prescribing, monitoring, or adherence.
Keywords: medication errors; hospital admission; drug treatment
This article has been cited by other articles:
![]() |
A. J. Leendertse, A. C. G. Egberts, L. J. Stoker, P. M. L. A. van den Bemt, and for the HARM Study Group Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands Arch Intern Med, September 22, 2008; 168(17): 1890 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Matheny, T. D. Sequist, A. C. Seger, J. M. Fiskio, M. Sperling, D. Bugbee, D. W. Bates, and T. K. Gandhi A Randomized Trial of Electronic Clinical Reminders to Improve Medication Laboratory Monitoring J. Am. Med. Inform. Assoc., July 1, 2008; 15(4): 424 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kongkaew, P. R Noyce, and D. M Ashcroft Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies Ann. Pharmacother., July 1, 2008; 42(7): 1017 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Howard, A Avery, and P Bissell Causes of preventable drug-related hospital admissions: a qualitative study Qual. Saf. Health Care, April 1, 2008; 17(2): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
E M A Witherington, O M Pirzada, and A J Avery Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study Qual. Saf. Health Care, February 1, 2008; 17(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Thomsen, A. G Winterstein, B. Sondergaard, L. S. Haugbolle, and A. Melander Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care Ann. Pharmacother., September 1, 2007; 41(9): 1411 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. George, K. Munro, D. J McCaig, and D. C Stewart Prescription Medications: Beliefs, Experiences, Behavior, and Adherence of Sheltered Housing Residents Ann. Pharmacother., December 1, 2006; 40(12): 2123 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Morris, J A Cantrill, A J Avery, and R L Howard Preventing drug related morbidity: a process for facilitating changes in practice. Qual. Saf. Health Care, April 1, 2006; 15(2): 116 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Maidment and A. Thorn A medication error reporting scheme: analysis of the first 12 months Psychiatr. Bull., August 1, 2005; 29(8): 298 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Howard Is Drug Monitoring a Main Cause of Excessive Anticoagulation? Arch Intern Med, February 14, 2005; 165(3): 349 - 349. [Full Text] [PDF] |
||||
![]() |
M. Pirmohamed, S. James, S. Meakin, C. Green, A. K Scott, T. J Walley, K. Farrar, B K. Park, and A. M Breckenridge Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ, July 3, 2004; 329(7456): 15 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Morris, S Rodgers, V S Hammersley, A J Avery, and J A Cantrill Indicators for preventable drug related morbidity: application in primary care Qual. Saf. Health Care, June 1, 2004; 13(3): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P Wyatt and M Campbell JournalScan Emerg. Med. J., March 1, 2004; 21(2): 205 - 206. [Full Text] [PDF] |
||||
![]() |
A J Avery Classifying and identifying errors Qual. Saf. Health Care, December 1, 2003; 12(6): 404 - 404. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |